We are live on ! Find out more
NVO

Novo Nordisk
NVO

1,395 hedge funds and large institutions have $16.7B invested in Novo Nordisk in 2025 Q3 according to their latest regulatory filings, with 159 funds opening new positions, 503 increasing their positions, 550 reducing their positions, and 224 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.23% less ownership

Funds ownership: 9.1% → 8.87% (-0.23%)

9% less repeat investments, than reductions

Existing positions increased: 503 | Existing positions reduced: 550

6% less funds holding

Funds holding: 1,481 → 1,395 (-86)

22% less capital invested

Capital invested by funds: $21.3B → $16.7B (-$4.59B)

29% less first-time investments, than exits

New positions opened: 159 | Existing positions closed: 224

32% less call options, than puts

Call options by funds: $2.04B | Put options by funds: $2.99B

32% less funds holding in top 10

Funds holding in top 10: 25 → 17 (-8)

Holders
1,395
Holders Change
-86
Holders Change %
-5.81%
% of All Funds
18.31%
Holding in Top 10
17
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-32%
% of All Funds
0.22%
New
159
Increased
503
Reduced
550
Closed
224
Calls
$2.04B
Puts
$2.99B
Net Calls
-$946M
Net Calls Change
-$454M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$800M
2
Capital International Investors
Capital International Investors
California
+$357M
3
Boston Partners
Boston Partners
Massachusetts
+$326M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$210M
5
Citadel Advisors
Citadel Advisors
Florida
+$160M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$1.03B
2
ClearBridge Investments
ClearBridge Investments
New York
-$429M
3
SGA
Sustainable Growth Advisers
Connecticut
-$362M
4
Fayez Sarofim & Co
Fayez Sarofim & Co
Texas
-$184M
5
N
Nuveen
North Carolina
-$145M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFG
1351
CKW Financial Group
Hawaii
$4K +$585 +10 +20%
DF
1352
DecisionPoint Financial
Arizona
$3.91K – – –
HCM
1353
Horrell Capital Management
Arkansas
$3.88K -$293 -5 -7%
HI
1354
Hoey Investments
Pennsylvania
$3.77K – – –
BDPWM
1355
Barnes Dennig Private Wealth Management
Ohio
$3.77K – – –
EP
1356
Essential Partners
California
$3.72K +$3.92K +67 New
CFS
1357
CGC Financial Services
Oregon
$3.61K – – –
NIG
1358
NFJ Investment Group
Texas
$3.5K -$5.03M -85,925 -100%
FG
1359
Fairman Group
Pennsylvania
$3.5K +$3.69K +63 New
DPW
1360
DiNuzzo Private Wealth
Pennsylvania
$3.39K – – –
DAM
1361
Delta Asset Management
Tennessee
$3.33K – – –
HWM
1362
HighMark Wealth Management
Minnesota
$3.26K – – –
KG
1363
Kilter Group
New York
$3.16K +$702 +12 +27%
CHC
1364
City Holding Co
West Virginia
$2.83K +$2.98K +51 New
AWM
1365
Accredited Wealth Management
Kentucky
$2.77K -$1.76K -30 -60%
CWM
1366
Crowley Wealth Management
Delaware
$2.77K – – –
CFG
1367
Clayton Financial Group
Missouri
$2.77K +$2.93K +50 New
WWA
1368
Wealth Watch Advisors
Colorado
$2.72K +$2.87K +49 New
NMG
1369
New Millennium Group
Utah
$2.55K – – –
ACA
1370
American Capital Advisory
Idaho
$2.39K +$2.52K +43 New
RTC
1371
Riverview Trust Company
Washington
$2.33K – – –
RF
1372
Robinswood Financial
Washington
$2.27K – – –
IWM
1373
IMG Wealth Management
Florida
$2.16K – – –
CTB
1374
Country Trust Bank
Illinois
$2.11K – – –
SJIM
1375
St. Johns Investment Management
Florida
$2.11K – – –
53 54
55
56 57

NVO Hedge Fund Activity: Q3 2025 in Review

1,395 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2025, worth a combined $16.7B — down 22% from $21.3B a quarter earlier.

Sellers outnumbered buyers: 224 funds closed out of NVO and 159 opened new positions — a net loss of 65 holders — while 550 trimmed existing stakes and 503 added.

The largest buyer was Franklin Resources, adding an estimated $800M. The largest seller was Jennison Associates, cutting an estimated $1.03B.

  • 1,395 institutional investors held Novo Nordisk (NVO) as of Q3 2025, down from 1,481 in Q2 2025.
  • Funds reported $16.7B of Novo Nordisk stock for Q3 2025, down 22% quarter-over-quarter.
  • 159 funds opened new Novo Nordisk positions in Q3 2025 and 224 closed out, a net change of -65 holders.
  • The largest Novo Nordisk buyer in Q3 2025 was Franklin Resources, an estimated $800M added.
  • The largest Novo Nordisk seller in Q3 2025 was Jennison Associates, an estimated $1.03B sold.

Based on aggregated 13F filings for Q3 2025.